Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002451796 | SCV002614425 | uncertain significance | Inborn genetic diseases | 2017-09-25 | criteria provided, single submitter | clinical testing | The c.3379-5C>G intronic variant results from a C to G substitution 5 nucleotides upstream from coding exon 13 in the CHD7 gene. This nucleotide position is not well conserved in available vertebrate species. This alteration is predicted to decrease the efficiency of the native splice acceptor site by the BDGP and ESEfinder in silico models; however experimental evidence is not currently available. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV005096252 | SCV005772933 | likely benign | CHARGE syndrome | 2024-12-05 | criteria provided, single submitter | clinical testing |